This morning, AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) announced that it received a "Notice of Allowance" from the United States Patent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE